Skip to main content

Table 2 imaging characteristic of 18F-FDG PET/CT in patients with NTM infection

From: The additional value of 18F-FDG PET/CT imaging in guiding the treatment strategy of non-tuberculous mycobacterial patients

Imaging characteristic

n (range or %)

Intra-pulmonary FDG accumulation

22(95.7)

Single lobe

5(21.7)

Double lobe

17(73.9)

Morphological manifestations in the lung

Patchy infiltration

18(81.8)

Nodular infiltration

3(13.6)

Bronchiectasis

8(36.4)

Cavitation

5(22.7)

Calcification

3(13.6)

Atelectasis

2(9.1)

Pleural effusion

4(18.2)

Extra- pulmonary FDG accumulation

17(73.9)

Lymph nodes

14(60.9)

Bone

6(26.1)

Subcutaneous

1(4.3)

Spleen

1(4.3)

Adrenal gland

1(4.3)

Extent of lesion involvement

 

Pulmonary NTM group

6(26.1)

Disseminated NTM group

17(73.9)

Metabolic parameters

mean (range)

SUVTop

8.2 ± 5.7 (1.2–28.1)

SUVI−lung

6.6 ± 3.9 (1.2–13.9)

SUVE−lung

6.3 ± 6.3 (1.8–28.1)

SUVLiver

2.7 ± 0.6 (1.7–3.8)

SUVMarrow

3.7 ± 2.0 (1.7–6.7)

SUVSpleen

2.5 ± 0.9 (1.7-6.0)

SURLiver

3.7 ± 2.3 (0.5–7.6)

SURBlood

5.9 ± 3.9 (0.7–10.3)

MLV (cm3)

122.2 ± 211.7 (0-972.6)

TLG(ml*SUV)

526.9 ± 992.1 (0-4628.6)

  1. 18F-FDG PET/CT: 18F-fluorodeoxyglucose positron emission tomography/computed tomography; NTM: Non-tuberculous mycobacterial infection; SUVTop: The most FDG-avid lesion in the whole body; SUVI−lung: SUVmax of lung lesions, SUVE−lung: SUVmax of extra-lung lesions; SUVLiver: SUVmax of liver; SUVSpleen: SUVmax of spleen; SUVMarrow: SUVmax of marrow; SURLiver: SUVmax ratio of lesion-to-liver; SURBlood: SUVmax ratio of lesion-to-blood pool. MLV: the metabolic lesion volume; TLG: total lesion glycolysis